Sciclone Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sciclone Pharmaceuticals

Access the complete profile.

Sciclone Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	951 Mariners Island Blvd, Ste 300 San Mateo, CA 94404

Sciclone Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sciclone Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Sciclone Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sciclone Pharmaceuticals is a publicly traded company on using the ticker symbol SCLN. Detailed information on company financials and operating reports can be found here: : SCLN

Sciclone Pharmaceuticals Annual Revenue and Growth Rate

Sciclone Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sciclone Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Sciclone Pharmaceuticals is developing and marketing. Sciclone Pharmaceuticals doesn't have any recent trademark applications, indicating Sciclone Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SCICLONE PHARMACEUTICALS pharmaceutical drugs used for the treatment of infectious diseases, cancer and immune system disorders	06/18/1992
SCICLONE pharmaceutical drugs used for the treatment of infectious diseases, cancer and immune system disorders	05/19/1992

See all trademarks and details in the Full Report.

Market Share of Sciclone Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sciclone Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sciclone Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GILEAD SCIENCES	Foster City, CA	100
SCICLONE PHARMACEUTICALS	San Mateo, CA	1
DOMPE U.S.	San Mateo, CA	1
FORTY SEVEN	San Mateo, CA	0
REVIR THERAPEUTICS	Foster City, CA	0
MICURX PHARMACEUTICALS	Foster City, CA	0

Future Competition: Sciclone Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Sciclone Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)